Breaking News Instant updates and real-time market news.

PYPL

PayPal

$107.48

-1.32 (-1.21%)

09:54
04/18/19
04/18
09:54
04/18/19
09:54

PayPal down over 3% in early trading to $105.33

  • 24

    Apr

  • 09

    May

  • 14

    May

  • 11

    Jun

PYPL PayPal
$107.48

-1.32 (-1.21%)

04/17/19
UBSW
04/17/19
DOWNGRADE
Target $120
UBSW
Neutral
PayPal downgraded to Neutral from Buy at UBS
UBS analyst Eric Wasserstrom downgraded PayPal Holdings to Neutral from Buy while raising his price target for the shares to $120 from $101. The stock closed yesterday up 6c to $108.20. The analyst's analysis of PayPal's core operations indicates "limited beat-and-raise potential" over the next two years. Further, his "bull scenario" for Venmo monetization would only add 2% to his current 2020 earnings estimates. While Venmo maintains a leading competitive position in people-to-people payments, this competitive position will translate into "limited" revenue and net income contribution over the next two years, Wasserstrom tells investors in a research note. In addition, the analyst sees limited valuation upside in shares of PayPal at current levels.
04/17/19
LEHM
04/17/19
NO CHANGE
Target $125
LEHM
Overweight
PayPal price target raised to $125 from $117 at Barclays
Barclays analyst Ramsey El-Assal raised his price target for PayPal to $125 from $117 and reiterates an Overweight rating on the shares after on analysis on the company's global digital marketplaces opportunity. The global digital marketplace opportunity remains one of PayPal's most compelling, El-Assal tells investors in a research note. The a analyst says that even if China's largest marketplaces and Amazon (AMZN) are excluded, he sees a sizable opportunity for PayPal at other global platforms. For example, the 2021 total addressable volume of ex-China and ex-Amazon marketplaces not currently served by PayPal is around $413B, contends the analyst. El-Assal believes the company's opportunity outside the U.S. is "substantial."
04/17/19
MSCO
04/17/19
NO CHANGE
Target $113
MSCO
Overweight
PayPal maintains acceptance lead among retailers, says Morgan Stanley
Morgan Stanley analyst James Faucette said his analysis shows that PayPal now has acceptance at 76% of the top 500 U.S. internet retailers and that on a volume-weighted basis excluding Amazon (AMZN) the company's acceptance penetration was 79% in Q1. He believes this acceptance lead vs. other digital wallets is underappreciated by investors as a key indicator of future payment volume growth and should enable PayPal to grow at or above the rate of e-commerce ex-Amazon. Faucette raised his price target on PayPal shares to $113 from $103 and keeps an Overweight rating on the shares.
04/17/19
04/17/19
DOWNGRADE

Fly Intel: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. PayPal (PYPL) downgraded to Neutral from Buy at UBS with analyst Eric Wasserstrom saying his analysis of PayPal's core operations indicates "limited beat-and-raise potential" over the next two years. 2. GasLog Partners (GLOP) downgraded to Equal Weight from Overweight at Morgan Stanley with analyst Fotis Giannakoulis saying he believes the partnership's ability to accretively fund new dropdowns has become increasingly more challenging. 3. Bank of America (BAC) downgraded to Hold from Buy at Jefferies with analyst Kenneth Usdin saying he does not see enough upside to warrant a Buy rating. 4. Comerica (CMA) downgraded to Outperform from Strong Buy at Raymond James and to Hold from Buy at Jefferies. 5. Skyworks (SWKS) downgraded to Neutral from Outperform at Macquarie. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

BIIB

Biogen

$293.92

1.71 (0.59%)

07:33
12/13/19
12/13
07:33
12/13/19
07:33
Hot Stocks
Breaking Hot Stocks news story on Biogen »

Biogen to discontinue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIIB

Biogen

$293.92

1.71 (0.59%)

07:32
12/13/19
12/13
07:32
12/13/19
07:32
Hot Stocks
Biogen: Primary endpoint not statistically significant in Phase 2 PASSPORT study »

Biogen announced topline…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$305.76

2.01 (0.66%)

07:32
12/13/19
12/13
07:32
12/13/19
07:32
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

CG

Carlyle Group

$29.83

-0.36 (-1.19%)

07:31
12/13/19
12/13
07:31
12/13/19
07:31
Hot Stocks
Funds advised by Apax Partners to acquire Coalfire from Carlyle Group, Chertoff »

Funds advised by Apax…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

ADBE

Adobe

$305.76

2.01 (0.66%)

07:30
12/13/19
12/13
07:30
12/13/19
07:30
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

SAFM

Sanderson Farms

$166.66

2.5 (1.52%)

07:30
12/13/19
12/13
07:30
12/13/19
07:30
Initiation
Sanderson Farms initiated  »

Sanderson Farms initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Dec

ORCL

Oracle

$56.47

0.16 (0.28%)

07:30
12/13/19
12/13
07:30
12/13/19
07:30
Recommendations
Oracle analyst commentary  »

Oracle shares to come…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AVGO

Broadcom

$327.39

7.53 (2.35%)

07:28
12/13/19
12/13
07:28
12/13/19
07:28
Recommendations
Broadcom analyst commentary  »

Broadcom price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NCLH

Norwegian Cruise Line

$56.12

0.72 (1.30%)

07:27
12/13/19
12/13
07:27
12/13/19
07:27
Recommendations
Norwegian Cruise Line analyst commentary  »

Norwegian Cruise Line…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADBE

Adobe

$305.76

2.01 (0.66%)

07:26
12/13/19
12/13
07:26
12/13/19
07:26
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

ADBE

Adobe

$305.76

2.01 (0.66%)

07:25
12/13/19
12/13
07:25
12/13/19
07:25
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

DCP

DCP Midstream

$23.70

-0.56 (-2.31%)

07:25
12/13/19
12/13
07:25
12/13/19
07:25
Initiation
DCP Midstream initiated  »

DCP Midstream initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jan

07:25
12/13/19
12/13
07:25
12/13/19
07:25
Conference/Events
UBS analyst manley to hold an analyst/industry conference call »

Analyst Manley discusses…

TDOC

Teladoc

$77.06

-0.36 (-0.46%)

07:24
12/13/19
12/13
07:24
12/13/19
07:24
Initiation
Teladoc initiated  »

Teladoc initiated with an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AIMT

Aimmune

$31.60

0.78 (2.53%)

07:22
12/13/19
12/13
07:22
12/13/19
07:22
Downgrade
Credit Suisse downgrades Aimmune with peanut allergy approval widely expected »

Credit Suisse analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NDSN

Nordson

$162.94

-4.5 (-2.69%)

07:22
12/13/19
12/13
07:22
12/13/19
07:22
Downgrade
Nordson rating change  »

Nordson downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BLUE

Bluebird Bio

$84.00

-2.97 (-3.42%)

07:20
12/13/19
12/13
07:20
12/13/19
07:20
Upgrade
Bluebird Bio rating change  »

Bluebird Bio upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

07:19
12/13/19
12/13
07:19
12/13/19
07:19
Upgrade
Bristol-Myers rating change  »

Bristol-Myers upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BNS

Bank of Nova Scotia

$56.73

0.145 (0.26%)

07:19
12/13/19
12/13
07:19
12/13/19
07:19
Downgrade
Bank of Nova Scotia rating change  »

Bank of Nova Scotia…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

SKX

Skechers

$41.65

0.89 (2.18%)

07:18
12/13/19
12/13
07:18
12/13/19
07:18
Upgrade
Skechers rating change  »

Skechers upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETSY

Etsy

$41.97

0.95 (2.32%)

07:17
12/13/19
12/13
07:17
12/13/19
07:17
Initiation
Etsy initiated  »

Etsy initiated with a Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SRPT

Sarepta

$100.39

-1.15 (-1.13%)

07:16
12/13/19
12/13
07:16
12/13/19
07:16
Recommendations
Sarepta price target raised to $260 from $160 at H.C. Wainwright »

H.C. Wainwright analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Walmart

$119.76

0.72 (0.60%)

07:15
12/13/19
12/13
07:15
12/13/19
07:15
Periodicals
Bonobos founder Andy Dunn leaving Walmart in 2020, CNBC reports »

Andy Dunn, the founder of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BGNE

BeiGene

$179.27

-0.33 (-0.18%)

, MRTX

Mirati Therapeutics

$106.24

0.39 (0.37%)

07:14
12/13/19
12/13
07:14
12/13/19
07:14
Hot Stocks
BeiGene announces clinical data on tislelizumab in combination with sitravatinib »

BeiGene (BGNE) and Mirati…

BGNE

BeiGene

$179.27

-0.33 (-0.18%)

MRTX

Mirati Therapeutics

$106.24

0.39 (0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

ADBE

Adobe

$305.76

2.01 (0.66%)

07:13
12/13/19
12/13
07:13
12/13/19
07:13
Recommendations
Adobe analyst commentary  »

Adobe price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.